Forbes Interview: FidoCure CEO Thinks Drugs For Dogs Can Help Humans Fight Cancer
Mammary Carcinoma: Insights from BRCA1 mutations
Genetic Signatures in Canine Mammary Tumors: insights from BRCA1 mutations
Veterinary Technician Week: Giveaway
Thank you to all the veterinary technicians who have helped us enroll over 4500 dogs on the FidoCure platform. We are so thankful for your partnership in fighting cancer on both ends of the leash! Enter below for your chance to win:
Case Study: Malignant Oral Melanoma
History and Treatment Planning Maggie, a friendly and rambunctious 12 year old, spayed female pug, was diagnosed with malignant oral melanoma in March 2022 by her primary care veterinarian. The mass was located on her upper left dental arcade. Her veterinarian surgically debulked approximately 80% of the mass. Unfortunately, Maggie experienced rapid local recurrence within […]
Fireside Chat with Dr. Len Lichtenfeld – Former Deputy Chief Medical Officer of American Cancer Society
Exclusive fireside chat with a distinguished trio of cancer experts: Dr. Len Lichtenfeld former Deputy Chief Medical Officer for the American Cancer Society (and FidoCure Scientific Advisory Board Member) with Dr. Gerry Post, Chief Medical Officer, FidoCure and Christina Lopes, CEO, FidoCure. Hear first-hand about their 8-year journey together in the fight against cancer on […]
The DNA from dog tumors may hold the secret to better human cancer drug
Cancer Does Not Have to Be a Death Sentence
Innovative Bioinformatics Pipeline Reduces Costs and Expands Access to Precision Therapeutics for Canine Oncology
Today we would like to share another exciting development in the field of canine oncology genetics and precision therapeutics from our manuscript “Shared Hotspot Mutations in Oncogenes Position Dogs as an Unparalleled Comparative Model for Precision Therapeutics,” recently published in Scientific Reports.
A Year of Breakthroughs: A look back at 2023
We would like to express our heartfelt gratitude to our veterinary community as we come to the close of the year. Together, we have made a tremendous impact by enabling precision medicine to nearly 5,000 pet dogs battling cancer.
Canine Melanoma: A Common, Aggressive Malignancy
Melanoma is an aggressive cancer arising from pigment-producing cells, accounting for 7% of canine tumors with certain breeds at higher risk. The most common form is oral melanoma, which affects the mouth and gums, and has the potential to metastasize. Cutaneous melanomas can also occur but are less common than oral melanomas and are often […]